Vedan­ta lays off CMC staffers; Kin­cell buys Imu­gene fa­cil­i­ty for $6M

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

Vedan­ta Bio­sciences will lay off 12 work­ers from its CMC team, and a “sim­i­lar num­ber” of staffers in oth­er po­si­tions, as the com­pa­ny is “com­ing off a peak of man­u­fac­tur­ing cam­paigns that sup­plied sev­er­al mid and late-stage clin­i­cal stud­ies,” CEO Bernat Olle wrote Fri­day on LinkedIn.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER